NCT00790933 An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease Status COMPLETED Phase PHASE3
NCT00787254 Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs Status COMPLETED Phase PHASE3
NCT00776074 A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids. Status COMPLETED Phase PHASE2
NCT00775840 Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients. Status COMPLETED Phase PHASE3
NCT00775814 Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension. Status COMPLETED Phase PHASE4
NCT00772174 Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00771004 Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation. Status COMPLETED Phase PHASE2
NCT00770952 Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE3
NCT00770835 Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE4
NCT00770653 Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia. Status COMPLETED Phase PHASE3
NCT00770640 Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure. Status COMPLETED Phase PHASE2
NCT00770575 Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease Status COMPLETED Phase PHASE2
NCT00770497 Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients. Status COMPLETED Phase PHASE2
NCT00770445 Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE4
NCT00763347 Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes Mellitus Status TERMINATED Phase PHASE2
NCT00763022 Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00762957 Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus. Status TERMINATED Phase PHASE3
NCT00762736 Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT00762684 Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus Status TERMINATED Phase PHASE3